MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
about
A PRISMA-compliant meta-analysis of MDM4 genetic variants and cancer susceptibility.MDM4 is a rational target for treating breast cancers with mutant p53.Targeting MDM4 Splicing in Cancers.Peptides and peptidomimetics in the p53/MDM2/MDM4 circuitry - a patent review.MBD2 upregulates miR-301a-5p to induce kidney cell apoptosis during vancomycin-induced AKI.MDMX under stress: the MDMX-MDM2 complex as stress signals hub
P2860
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
@en
type
label
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
@en
prefLabel
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
@en
P2860
P1476
MDMX (MDM4), a Promising Target for p53 Reactivation Therapy and Beyond.
@en
P2093
Aart G Jochemsen
P2860
P356
10.1101/CSHPERSPECT.A026237
P577
2016-07-01T00:00:00Z